2016
DOI: 10.1371/journal.pone.0147951
|View full text |Cite
|
Sign up to set email alerts
|

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation

Abstract: DNAX accessory protein-1 (DNAM-1, CD226) is a co-stimulatory and adhesion molecule expressed mainly by natural killer cells and T cells. DNAM-1 and its two ligands CD112 and CD155 are important in graft-versus-host disease, but their role in solid organ transplantation is largely unknown. We investigated the relevance of this pathway in a mouse kidney transplantation model. CD112 and CD155 are constitutively expressed on renal tubular cells and strongly upregulated in acutely rejected renal allografts. In vitr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
11
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 36 publications
(52 reference statements)
2
11
0
Order By: Relevance
“…In a previous study, Pfeiffer's team showed that blockade of CD155 resulted in decreased lysis of human hepatoblastoma cells ( 51 ), while Baofu's group demonstrated that blocking CD155 could enhance the proliferation of healthy CIK cells ( 52 ). In addition, Kraus' team found that the absence of CD112 or CD155 in kidney allografts did not significantly influence renal function ( 53 ). These discordant results may be attributable to CD155 biological function, which can combine with either TIGIT or CD226; hence, the results of CD155 blockage may be influenced by the ratio of TIGIT to CD226 expression levels.…”
Section: Discussionmentioning
confidence: 99%
“…In a previous study, Pfeiffer's team showed that blockade of CD155 resulted in decreased lysis of human hepatoblastoma cells ( 51 ), while Baofu's group demonstrated that blocking CD155 could enhance the proliferation of healthy CIK cells ( 52 ). In addition, Kraus' team found that the absence of CD112 or CD155 in kidney allografts did not significantly influence renal function ( 53 ). These discordant results may be attributable to CD155 biological function, which can combine with either TIGIT or CD226; hence, the results of CD155 blockage may be influenced by the ratio of TIGIT to CD226 expression levels.…”
Section: Discussionmentioning
confidence: 99%
“…24,25 Furthermore, following activation of innate and adaptive immune pathways, DSA could trigger additional infiltration of T cells and development of a mixed rejection type (ABMR/T-cell-mediated rejection [TCMR]). 27,28 To both ligands, back signaling capacities have been attributed. 27,28 To both ligands, back signaling capacities have been attributed.…”
Section: Introductionmentioning
confidence: 99%
“…26 Besides HLA class I, PTEC express other T/NK cell receptor ligands that may be involved in rejection, eg, CD155 and CD166. 27,28 To both ligands, back signaling capacities have been attributed.…”
Section: Introductionmentioning
confidence: 99%
“…CD112 and CD155 are constitutively expressed on renal tubular cells and strongly up‐regulated in acutely rejected renal allografts . However, CD226 blockade or the absence of CD112 or CD155 in the kidney allograft is not effective for preventing transplant rejection; the role of CD226 and its ligands remain largely unknown.…”
Section: Introductionmentioning
confidence: 99%
“…CD112 and CD155 are constitutively expressed on renal tubular cells and strongly up-regulated in acutely rejected renal allografts. 18 However, CD226 blockade or the absence of CD112 or CD155 in the kidney allograft is not effective for preventing transplant rejection; the role of CD226 and its ligands remain largely unknown. Recently, Eqelkamp et al suggested that CD155, HLA class І, and CD166 on renal epithelial cells interact with CD226 on T/NK effector cells, which contributes to the rejection-specific microenvironment in renal allograft.…”
mentioning
confidence: 99%